USD 174.20 Billion
Nanomedicine Market Size, Share, Growth Analysis, By Application Scope(Therapeutics, In-vitro Diagnostics, Drug Delivery, In-vivo Imaging), By Indication Scope(Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2200 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
67
|Figures:
75
Nanomedicine Market Insights
Global Nanomedicine Market size was valued at USD 174.20 Billion in 2022 and is poised to grow from USD 191.27 Billion in 2023 to USD 404.08 Billion by 2031, at a CAGR of 9.8% during the forecast period (2024-2031).
The primary purpose of the nanomedicine market is to develop innovative solutions that can address unmet medical needs and improve patient outcomes. Nanomedicine offers several advantages over traditional medical approaches, including enhanced drug delivery, improved bioavailability, reduced side effects, and targeted therapies. The goal is to leverage nanotechnology to develop advanced medical treatments that are more efficient, precise, and tailored to individual patients. Several driving factors contribute to the growth of the global nanomedicine market. Firstly, advancements in nanotechnology have provided new tools and techniques for precise manipulation and control at the nanoscale, opening up possibilities for novel medical applications. The nanomedicine market also faces certain restraining factors. One of the key challenges is the complex and expensive nature of nanomedicine development and manufacturing processes.
One of the major challenges is the scale-up and commercialization of nanomedicine products. While promising results are often achieved in research and preclinical stages, translating those findings into scalable and cost-effective commercial products poses significant challenges. The nanomedicine market presents significant opportunities for growth and innovation. As research in nanotechnology continues to advance, there is immense potential for the development of new therapeutic approaches and diagnostics. Nanomedicine offers the opportunity for targeted drug delivery systems, personalized medicine, and non-invasive imaging techniques. The global nanomedicine market aims to revolutionize healthcare by harnessing the potential of nanotechnology for improved diagnostics, targeted therapies, and personalized medicine. Advancements in nanotechnology, coupled with the rising prevalence of chronic diseases, drive the market's growth. However, challenges such as high costs, regulatory complexities, and scalability need to be addressed. Nonetheless, the market presents significant opportunities for innovative solutions that can transform healthcare delivery and improve patient outcomes.
US Nanomedicine Market is poised to grow at sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Drug Delivery
Fastest Growth
Therapeutics
Growth Rate
9.8% CAGR
Global Nanomedicine Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Nanomedicine Market Segmental Analysis
The global nanomedicine market is segmented on the basis of application scope, indication scope, and region. In terms of application scope, the market is segmented into therapeutics, in-vitro diagnostics, drug delivery, in-vivo imaging, and implants. Based on indication scope, the market is segmented into clinical oncology, infectious diseases, clinical cardiology, orthopedics, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Nanomedicine Market Analysis by Application Scope
In 2022, the drug delivery segment emerged as the dominant segment in the nanomedicine market, accounting for a significant share of 34.09%. This growth can be attributed to the increasing prevalence of chronic and infectious diseases, which has created a need for effective drug delivery systems. Additionally, the rising public awareness about the potential applications of nanomedicines has further fueled the demand for drug delivery solutions. Researchers and pharmaceutical companies are actively exploring the use of nanomedicines in drug delivery, leading to advancements in this segment. For example, in March 2023, researchers at Memorial Sloan Kettering Cancer Center and Mount Sinai Health System developed a targeted drug delivery method for treating brain tumors in children.
The therapeutics segment is expected to witness the fastest growth rate of 12.79% from 2023 to 2030. This segment encompasses various nanomedicine products used for therapeutic purposes, including medications, equipment, and drug delivery systems. The availability of a wide range of nanotherapeutics for the treatment of various ailments contributes to the growth of this segment. Moreover, advancements in technology have facilitated the development of nanotherapeutics that can effectively cross biological barriers, enabling targeted and precise treatments. These advancements are expected to drive the market for nanotherapeutics in the coming years.
Nanomedicine Market Analysis by Indication Scope
In 2022, the clinical oncology segment emerged as the dominant segment in the nanomedicine market, accounting for a significant share of 32.44%. This dominance can be attributed to the increasing prevalence of cancer disorders globally. The rising number of cancer treatment products in the clinical stages of development, along with advancements in therapeutic particles and devices, have contributed to the growth of this segment. Clinical oncology in the nanomedicine industry encompasses various active and passive cancer-targeting techniques, offering promising prospects for further growth in the market.
The infectious disease segment is expected to witness rapid growth, with a projected compound annual growth rate (CAGR) of 12.31% by 2030. This growth is driven by the growing need for the development of efficient, rapid, and cost-effective therapies for infectious diseases. Nanomedicine has emerged as a promising treatment modality due to its high targeting efficiency and reduced adverse effects. The unique properties of nanomedicine enable the targeting of a wide variety of infectious diseases, presenting significant growth opportunities for the nanomedicine industry in this segment.
Global Nanomedicine Market By Application Scope
To get detailed analysis on other segments, Request For Free Sample Report
Nanomedicine Market Regional Insights
In 2022, North America emerged as the dominant region in the nanomedicine market, capturing a significant share of 49.91%. The region is expected to maintain its leadership position throughout the forecast period. This growth can be attributed to the presence of expanding partnerships between established businesses and nanomedicine start-up companies. Moreover, the region benefits from strong support from governmental authorities and increasing investments in research and development. North America is also home to a considerable number of manufacturing firms actively engaged in strategic ventures in the nanomedicine industry. For example, Advanced NanoTherapies, a company focused on developing a drug delivery platform using nanoparticles for various applications, raised USD 5.3 million in seed-round financing in October 2020 to accelerate the development of its technology for treating peripheral artery disease.
Asia Pacific market is expected to exhibit the fastest compound annual growth rate (CAGR) of 14.07% during the period from 2023 to 2030. This growth can be attributed to the increasing awareness about nanomedicine and the active engagement of the public in consensus conferences related to nanoscience and nanotechnology. Notably, in August 2022, Beijing, China hosted the 9th International Conference on Nanoscience and Technology, China (ChinaNANO 2022). This conference served as a platform to disseminate scientific breakthroughs, advancements in specific industry sectors, technical innovations, and discuss new possibilities and challenges in the field of nanomedicine.
Global Nanomedicine Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Nanomedicine Market Dynamics
Nanomedicine Market Drivers
Increasing Prevalence of Chronic Diseases
- The rising incidence of chronic diseases such as cancer, cardiovascular disorders, and diabetes is a major driver for the nanomedicine market. Nanomedicine offers targeted and personalized therapies that can enhance treatment outcomes and improve patient quality of life.
Technological Advancements in Nanotechnology
- Continuous advancements in nanotechnology have paved the way for innovative nanomedicine solutions. Improved drug delivery systems, enhanced imaging techniques, and the development of nanoscale diagnostic tools have expanded the possibilities for nanomedicine applications, driving market growth.
Nanomedicine Market Restraints
High Development Costs
- The development and commercialization of nanomedicine products involve significant research and development costs. The complex manufacturing processes and regulatory requirements contribute to the high cost of bringing nanomedicine products to market, which can hinder widespread adoption.
Safety Concerns
- Ensuring the safety and biocompatibility of nanomedicine products is crucial for their successful implementation. The potential toxicity and long-term effects of nanoparticles on human health are still being studied. Addressing safety concerns and gaining regulatory approvals pose challenges to the market growth.
Request Free Customization of this report to help us to meet your business objectives.
Nanomedicine Market Competitive Landscape
The global nanomedicine market is highly competitive and comprises a mix of established pharmaceutical companies, biotechnology firms, research institutions, and emerging nanomedicine startups. These players are actively involved in research and development, strategic collaborations, mergers and acquisitions, and product launches to gain a competitive edge in the market. The global nanomedicine market is characterized by intense competition, continuous research and development, and strategic collaborations. With the increasing adoption of nanotechnology in healthcare, the competitive landscape is expected to evolve further as companies strive to capitalize on the immense potential of nanomedicine in improving patient outcomes and addressing unmet medical needs.
Nanomedicine Market Top Player’s Company Profiles
- Pfizer Inc. (US)
- Novartis International AG (Switzerland)
- Johnson & Johnson (US)
- Merck & Co., Inc. (US)
- Abbott Laboratories (US)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Gilead Sciences, Inc. (US)
- Celgene Corporation (US)
- Amgen Inc. (US)
- GlaxoSmithKline plc (UK)
- AstraZeneca plc (UK)
- Sanofi S.A. (France)
- Roche Holding AG (Switzerland)
- Eli Lilly and Company (US)
- Bristol-Myers Squibb Company (US)
- Biogen Inc. (US)
- Takeda Pharmaceutical Company Limited (Japan)
- Boehringer Ingelheim International GmbH (Germany)
- Bayer AG (Germany)
- Astellas Pharma Inc. (Japan)
Nanomedicine Market Recent Developments
- In February 2024, University of Sydney signed precision-medicine research partnership with Bruker. The strategic partnership will place the University of Sydney in a leading position internationally to advance nanomedicine, gene therapies and the early detection, treatment and prevention of disease.
- In September 2023, Evonik, a contract development and manufacturing organization (CDMO) for complex parenterals, announced that it is strengthening its platform of parenteral drug delivery solutions with three new standard PLA-PEG di-block copolymers and a new nanoparticle formulation service using sonication technology.
- In August 2023, Frasle Mobility initiated the commercialization of the Maxcoating Brake Disc line under its Fremax brand. Officially launched in April at the Automec fair in Brazil, the line brings discs and brake drums coated with paint that contains exclusive, patented nanotechnology to the global market.
- In October 2022, researchers at the University of Toronto developed a nanomedicine platform that uses nanoparticles to target and destroy cancer cells while leaving healthy cells unharmed.
- In August 2022, a team of scientists at MIT developed a new type of nanomedicine that can deliver multiple drugs simultaneously to treat pancreatic cancer.
Nanomedicine Key Market Trends
- Personalized Medicine: Nanomedicine enables personalized treatment approaches by delivering drugs or therapies based on an individual's specific needs. The trend towards personalized medicine is driving the adoption of nanomedicine, as it allows for targeted and tailored treatments.
- Combination Therapies: The integration of nanomedicine with other treatment modalities, such as immunotherapy and gene therapy, is a growing trend. Combining different therapeutic approaches can enhance treatment efficacy, overcome drug resistance, and provide synergistic effects, opening new possibilities for nanomedicine applications.
Nanomedicine Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global nanomedicine market analysis, the increasing prevalence of chronic diseases, advancements in nanotechnology, and the need for personalized medicine are the key drivers. Nanomedicine offers advantages such as targeted drug delivery, reduced side effects, and improved efficacy. However, the market also faces challenges such as high development costs, regulatory concerns, and ethical considerations. Despite these challenges, the market presents significant opportunities, such as the development of novel therapies, collaborations between academia and industry, and the potential for precision medicine. With ongoing research and technological advancements, the global nanomedicine market is expected to witness substantial growth in the coming years.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 174.20 Billion |
| Market size value in 2031 | USD 404.08 Billion |
| Growth Rate | 9.8% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Nanomedicine Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Nanomedicine Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Nanomedicine Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Nanomedicine Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Nanomedicine Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Nanomedicine Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
